Skip Navigation

European Heart Journal 1995 16(2):253-256;
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by CORRAO, S.
Right arrow Articles by LICATA, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CORRAO, S.
Right arrow Articles by LICATA, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease

S. CORRAO, L. SALLI', S. ARNONE, R. SCAGLIONE, V. AMATO, M. CECALA, A. LICATA and G. LICATA

Institute of Internal Medicine, University of Palermo Palermo, Italy

Received 7 January 1994; revised 6 May 1994; accepted 1 August 1994.

Correspondence: Salvatore Corrao, MD Cattedra di Patologia Medica I (Dir G. Licata), Piazza Ddle Cliniche, 2, 90127 Palermo, Italy.

Abstract

Background: Rlieumatoid arthritis (RA) is a systemic disease involving many organ systems and is frequently accompanied by cardiac alterations. However, there is considerable disagreement concerning the cardiac abnormalities found in patients with RA.

The purpose of our investigation was to determine, by a non-invasive method such as echocardiography, the nature and extent of cardiac involvement in RA patients with no symptoms of cardiac disease, in comparison with a control sample.

Methods: We selected 35 patients affected by rheumatoid arthritis (five men, 30 women), aged 51 ± 11 years. No patient had either symptoms of cardiac disease or extra cardiac complaint.

As a control group we studied 52 volunteers, aged 51 ± 12 years, randomly selected among a larger group of subjects with no symptoms, signs and/or clinical findings of extra cardiac diseases. All were in sinus rhythm and without any cardiac symptom.

Standard two-dimensional, M-mode and Doppler echocardiographic examination was carried out on each subject.

Results: In RA patients we found a higher prevalence of several abnormalities. We found no statistically significant differences between the groups of RA patients based on the stage and duration of disease. We found no correlation between cardiac abnormalities and inflammatory indices or drug therapy.

Discussion: At least three alterations seem to be typical of RA patients in the absence of any symptom of cardiac disease: (1) posterior pericardial effusion, (2) aortic root alterations and (3) valvular thickening. The prevalence of MVP is controversial and needs furtlier investigation. These alterations are variously combined in each patient, and for this reason we think that it is possible to represent such a heart involvement as ‘silent rheumatoid heart disease’.

Moreover the knowledge of the presence of unrecognised cardiac abnormalities can be very important for the correct assessment and management of the RA patient.

Key Words: Rheumatoid arthritis • cardiac abnormalities • echocardiography


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
J. K. Dawson, N. G. Goodson, D. R. Graham, and M. P. Lynch
Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients
Rheumatology, December 1, 2000; 39(12): 1320 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. Di Franco, M. Paradiso, A. Mammarella, V. Paoletti, G. Labbadia, L. Coppotelli, E. Taccari, and A. Musca
Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease
Ann Rheum Dis, March 1, 2000; 59(3): 227 - 229.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.